Vivani Medical Inc (VANI)

$1.28

-0.02

(-1.54%)

Market is closed - opens 7 PM, 24 Jul 2024

Performance

  • $1.28
    $1.30
    $1.28
    downward going graph

    0.0%

    Downside

    Day's Volatility :1.54%

    Upside

    1.54%

    downward going graph
  • $0.84
    $7.80
    $1.28
    downward going graph

    34.38%

    Downside

    52 Weeks Volatility :89.23%

    Upside

    83.59%

    downward going graph

Returns

PeriodVivani Medical IncIndex (Russel 2000)
3 Months
-27.78%
0.0%
6 Months
27.45%
0.0%
1 Year
3.17%
0.0%
3 Years
-68.6%
-19.9%

Highlights

Market Capitalization
69.3M
Book Value
$0.52
Earnings Per Share (EPS)
-0.5
Wall Street Target Price
8.0
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-33.79%
Return On Equity TTM
-75.65%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
130.0K
EBITDA
-26.2M
Diluted Eps TTM
-0.5
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.5
EPS Estimate Next Year
-0.56
EPS Estimate Current Quarter
-0.12
EPS Estimate Next Quarter
-0.12

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Vivani Medical Inc(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 525.0%

Current $1.28
Target $8.00

Technicals Summary

Sell

Neutral

Buy

Vivani Medical Inc is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Vivani Medical Inc
Vivani Medical Inc
5.69%
27.45%
3.17%
-68.6%
-68.6%
Moderna, Inc.
Moderna, Inc.
-10.58%
20.19%
-0.41%
-64.88%
800.74%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
0.55%
12.06%
47.12%
82.44%
245.9%
Novo Nordisk A/s
Novo Nordisk A/s
-6.4%
26.39%
64.35%
193.51%
440.83%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
4.41%
12.78%
38.89%
147.34%
182.99%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Vivani Medical Inc
Vivani Medical Inc
NA
NA
NA
-0.5
-0.76
-0.34
NA
0.52
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.18
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.45
31.45
1.46
44.4
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
45.05
45.05
2.36
3.45
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.94
31.94
0.53
17.05
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Vivani Medical Inc
Vivani Medical Inc
Buy
$69.3M
-68.6%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$46.4B
800.74%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$117.2B
245.9%
31.45
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$591.7B
440.83%
45.05
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.9B
182.99%
31.94
39.46%

Insights on Vivani Medical Inc

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 60.8% return, outperforming this stock by 59.2%

Institutional Holdings

  • Sabby Management LLC

    4.86%
  • Tanager Wealth Management LLP

    2.37%
  • Vanguard Group Inc

    1.55%
  • Commonwealth Equity Services Inc

    0.64%
  • Geode Capital Management, LLC

    0.57%
  • Monetary Management Group Inc

    0.35%

Company Information

vivani leverages proprietary technologies to develop and commercialize drug and device implants, including its lead asset npm-119 (exenatide implant), which seeks to treat patients with chronic diseases with high unmet medical need.

Organization
Vivani Medical Inc
Employees
36
CEO
Mr. Adam Mendelsohn Ph.D.
Industry
Miscellaneous

FAQs